Center receives $6.5 million to test, develop new cancer drugs
UC Davis Cancer Center has received a $6.5 million award from the
National Cancer Institute to offer innovative new therapies for
people with cancer.
five-year award will fund research of anti-cancer drugs in phase
II clinical trials. Phase II trials test the safety and effectiveness
of treatments, many of which have benefited people with cancer but
which may not have been approved by the U.S. Food and Drug Administration.
are performed under the auspices of the California Cancer Consortium,
a collaborative, NCI-funded group consisting of the UC Davis Cancer
Center, City of Hope National Medical Center and the University
of Southern California Norris Comprehensive Cancer Center.
the California Cancer Consortium's inception six years ago, more
than 1,000 patients have participated in research studies sponsored
by the group. Many have benefited from these groundbreaking studies
by extending their survival and improving their quality of life
while battling cancer.
Gandara, a professor of medicine at the UC Davis School of Medicine
and Medical Center and associate director of clinical research for
the UC Davis Cancer Center, is principal investigator of the program.
award allows us to offer more effective and less toxic therapies
for cancer, including targeted biological treatments that modify
cancer genes," he said. "These will be available to consortium
patients years before they are available to the general public."
Davis' award is the largest of the eight contracts awarded by the
NCI's Cancer Therapy Evaluation Program this year and is the only
one given to an institution on the West Coast. The evaluation program
oversees clinical research programs nationwide in an effort to expedite
investigational therapies considered interesting, promising, and
the award requires that researchers demonstrate the biological effectiveness
of new drugs, more than 50 clinicians, pathologists, molecular biologists
and pharmacologists will participate in designing and conducting
Table of Contents |
To our Readers |
Building on Basics
Focusing on Patients |
In Translation |
Campus Connection |
News in Brief
UC Davis Health System |
© 2000, 2001, 2002 UC Regents. All rights reserved.